OTCMKTS:PURE - Pure Bioscience Stock Price, News, & Analysis

Sign in or create an account to add this stock to your watchlist.
$0.50 +0.02 (+4.17 %)
(As of 12/14/2018 04:00 PM ET)
Previous Close$0.50
Today's Range$0.42 - $0.50
52-Week Range$0.3840 - $1.02
Volume97,402 shs
Average Volume23,455 shs
Market Capitalization$34.36 million
P/E RatioN/A
Dividend YieldN/A
PURE Bioscience, Inc. develops and commercializes antimicrobial products that provide solutions to the health and environmental challenges of pathogen and hygienic control in the United States and internationally. It manufactures and distributes silver dihydrogen citrate (SDC), a non-toxic antimicrobial agent, which offers residual protection and formulates with other compounds. The company offers SDC-based disinfecting and sanitizing products, including PURE Hard Surface, a food contact surface sanitizer and disinfectant; PURE Control, a food contact processing aid for fresh produce and raw poultry; PURE Multi-Purpose and Floor Cleaner Concentrate used to clean various resilient surfaces, including floors, glass, and food contact surfaces; and PURE Multi-Purpose Hi-Foam Cleaner Concentrate used to clean stainless steel equipment, resilient floors, walls, and painted surfaces. Its SDC-based disinfecting and sanitizing products comprising Axen30, a hard surface disinfectant; Axenohl, an antimicrobial formulation used as a raw material ingredient in the manufacturing of consumer and commercial disinfecting and sanitizing products; and SILVÉRION, an antimicrobial solution used against bacteria, viruses, yeast, and molds. It sells its products to distributors and end users. PURE Bioscience, Inc. was founded in 1992 and is headquartered in El Cajon, California.

Receive PURE News and Ratings via Email

Sign-up to receive the latest news and ratings for PURE and its competitors with MarketBeat's FREE daily newsletter.

Industry, Sector and Symbol

Stock Exchange OTCMKTS
Industry Miscellaneous chemical products
Current SymbolOTCMKTS:PURE
Previous Symbol


Debt-to-Equity RatioN/A
Current Ratio1.13
Quick Ratio0.98


Trailing P/E RatioN/A
Forward P/E RatioN/A
P/E GrowthN/A

Sales & Book Value

Annual Sales$1.77 million
Price / Sales20.22
Cash FlowN/A
Price / Cash FlowN/A
Book Value$0.02 per share
Price / Book25.00


EPS (Most Recent Fiscal Year)($0.11)
Net Income$-7,440,000.00
Net Margins-403.63%
Return on Equity-342.88%
Return on Assets-246.33%


Outstanding Shares71,580,000
Market Cap$34.36 million
OptionableNot Optionable

Pure Bioscience (OTCMKTS:PURE) Frequently Asked Questions

What is Pure Bioscience's stock symbol?

Pure Bioscience trades on the OTCMKTS under the ticker symbol "PURE."

How were Pure Bioscience's earnings last quarter?

Pure Bioscience, Inc. (OTCMKTS:PURE) announced its quarterly earnings data on Thursday, December, 13th. The company reported ($0.04) earnings per share for the quarter. The business earned $0.59 million during the quarter. Pure Bioscience had a negative net margin of 403.63% and a negative return on equity of 342.88%. View Pure Bioscience's Earnings History.

When is Pure Bioscience's next earnings date?

Pure Bioscience is scheduled to release their next quarterly earnings announcement on Wednesday, March 13th 2019. View Earnings Estimates for Pure Bioscience.

Has Pure Bioscience been receiving favorable news coverage?

Media headlines about PURE stock have been trending very negative on Saturday, InfoTrie reports. InfoTrie ranks the sentiment of media coverage by reviewing more than six thousand news and blog sources in real time. The firm ranks coverage of publicly-traded companies on a scale of negative five to five, with scores nearest to five being the most favorable. Pure Bioscience earned a news sentiment score of -3.8 on InfoTrie's scale. They also gave news stories about the company a news buzz of 10.0 out of 10, indicating that recent media coverage is extremely likely to have an effect on the company's share price in the next few days.

Who are some of Pure Bioscience's key competitors?

Who are Pure Bioscience's key executives?

Pure Bioscience's management team includes the folowing people:
  • Mr. Henry R. Lambert, CEO & Director (Age 67)
  • Mr. Mark Stuart Elliott, VP of Fin. (Age 43)
  • Mr. Thomas Richard Myers, Chief Operating Officer (Age 66)
  • Ms. Bridget C. Tinsley-Cormier M.S., Sr. VP of Technology & Bus. Devel. and VP of Market Devel.
  • Mr. Cliff Wechsler, Exec. VP of Sales

How do I buy shares of Pure Bioscience?

Shares of PURE can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.

What is Pure Bioscience's stock price today?

One share of PURE stock can currently be purchased for approximately $0.50.

How big of a company is Pure Bioscience?

Pure Bioscience has a market capitalization of $34.36 million and generates $1.77 million in revenue each year. The company earns $-7,440,000.00 in net income (profit) each year or ($0.11) on an earnings per share basis. Pure Bioscience employs 11 workers across the globe.

What is Pure Bioscience's official website?

The official website for Pure Bioscience is http://www.purebio.com.

How can I contact Pure Bioscience?

Pure Bioscience's mailing address is 1725 GILLESPIE WAY, EL CAJON CA, 92020. The company can be reached via phone at 619-596-8600.

MarketBeat Community Rating for Pure Bioscience (OTCMKTS PURE)

Community Ranking:  2.5 out of 5 (star star half star)
Outperform Votes:  69 (Vote Outperform)
Underperform Votes:  67 (Vote Underperform)
Total Votes:  136
MarketBeat's community ratings are surveys of what our community members think about Pure Bioscience and other stocks. Vote "Outperform" if you believe PURE will outperform the S&P 500 over the long term. Vote "Underperform" if you believe PURE will underperform the S&P 500 over the long term. You may vote once every thirty days.
This page was last updated on 12/15/2018 by MarketBeat.com Staff

Featured Article: What is Depreciation?

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.

Yahoo Gemini Pixel